Search results
Results From The WOW.Com Content Network
It is published by Elsevier and the editor-in-chief is Marianna Kruithof-de Julio (University of Bern) The Gene Family of journals comprises the journals Gene, Gene Reports, Human Gene, and Plant Gene. According to the Journal Citation Reports, the journal has a 2022 impact factor of 3.5. [1]
During the COVID-19 pandemic, there has been interest in vitamin D status and supplements, given the significant overlap in the risk factors for severe COVID-19 and vitamin D deficiency. [196] These include obesity, older age, and Black or Asian ethnic origin, and it is notable that vitamin D deficiency is particularly common within these groups.
Genes is a quarterly peer-reviewed open access scientific journal that is published by MDPI. The editor-in-chief is J. Peter W. Young (University of York). [1] It covers all topics related to genes, genetics, and genomics.
[52] [53] [54] As of July 2021, a large number of drugs had been considered for treating COVID-19 patients. [55] As of November 2022, there was moderate-certainty evidence suggesting that dexamethasone, and systemic corticosteroids in general, probably cause a slight reduction in all-cause mortality (up to 30 days) in hospitalized patients with ...
The Journal of Gene Medicine is a monthly peer-reviewed medical ... the journal has a 2020 impact factor of 4 ... This page was last edited on 12 September 2024, ...
COVID-19: Shionogi: 3C-like protease inhibitor Entecavir: HIV NRTI 2005 Etravirine (Intelence) [8] HIV NNRTI 2008 Famciclovir: Herpes Zoster: Guanosine analogue 1994 Fomivirsen: AIDS Anti-sense oligonucleotide: Anti-sense FDA-licensed in 1998; Withdrawn in EU (2002), US (2006) Fosamprenavir: HIV ViiV Healthcare: Amprenavir pro-drug: 2003 (FDA ...
COVID-19 vaccines are not gene therapy and a Forbes article doesn’t say they are. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 more ways to reach us. Sign in ...
This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.